Cargando…
Universal Tre (uTre) recombinase specifically targets the majority of HIV-1 isolates
Current drugs against HIV can suppress the progression to AIDS but cannot clear the patient from the virus. Because of potential side effects of these drugs and the possible development of drug resistance, finding a cure for HIV infection remains a high priority of HIV/AIDS research. We recently gen...
Autores principales: | Karpinski, Janet, Chemnitz, Jan, Hauber, Ilona, Abi-Ghanem, Josephine, Paszkowski-Rogacz, Maciej, Surendranath, Vineeth, Chakrabort, Debojyoti, Hackmann, Karl, Schröck, Evelin, Teresa Pisabarro, María, Hauber, Joachim, Buchholz, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225392/ https://www.ncbi.nlm.nih.gov/pubmed/25397454 http://dx.doi.org/10.7448/IAS.17.4.19706 |
Ejemplares similares
-
Next-generation LTR-specific Tre-recombinase targets a majority of HIV-1 isolates
por: Hauber, Joachim, et al.
Publicado: (2014) -
Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice
por: Hauber, Ilona, et al.
Publicado: (2013) -
Excision of HIV-1 Proviral DNA by Recombinant Cell Permeable Tre-Recombinase
por: Mariyanna, Lakshmikanth, et al.
Publicado: (2012) -
Un an après une pneumonie à COVID-19 : aspect scanographique et facteurs prédictifs des séquelles pulmonaires
por: Feki, W., et al.
Publicado: (2023) -
Study of the effects of nanoplastics ingestion in a freshwater fish (Danio rerio)
por: Brand, Simon, et al.
Publicado: (2021)